Neuromuscular Disorders Market Report Infographic Image

Published : April 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Neuromuscular Disorders Market Report 2026

Name: Neuromuscular Disorders Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Disease Type (Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS), Duchenne Muscular Dystrophy (DMD), Myasthenia Gravis, Other Muscular Dystrophies), By Product Type (Pharmaceuticals, Biologics, Diagnostic Tools, Assistive Devices), By Route of Administration (Oral, Injectable, Other Route of Administrations), By Treatment (Gene Therapy, Drug Therapy, RNA-Based Therapy, Enzyme Replacement Therapy, Physical Therapy And Rehabilitation, Respiratory Care) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Neuromuscular Disorders Market Overview

• Neuromuscular Disorders market size has reached to $8.31 billion in 2025

• Expected to grow to $12.07 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%

• Growth Driver: Rising Demand For Personalized Medicine Fueling The Growth Of The Market Due To Targeted, Patient-Specific Therapies

• Market Trend: Expansion Of Gene Therapy Options Improves Treatment Access Across Age Groups

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neuromuscular Disorders Market?

Neuromuscular disorders are a group of medical conditions that affect the nerves and muscles, leading to weakness, loss of movement, or impaired function. They occur when communication between the nervous system and muscles is disrupted due to genetic, autoimmune, or degenerative causes. These disorders often progress over time and require ongoing medical management, therapy, and supportive care.

The main disease types of neuromuscular disorder include spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy (DMD), myasthenia gravis, and others. Spinal muscular atrophy (SMA) refers to a genetic disorder characterized by the loss of motor neurons, leading to progressive muscle weakness and atrophy, and requires targeted clinical management to improve patient outcomes. The variety of product types including pharmaceuticals, biologics, diagnostic tools, and assistive devices. The routes of administration such as oral, injectable, and others. The treatment approaches encompass gene therapy, drug therapy, RNA-based therapy, enzyme replacement therapy, physical therapy and rehabilitation, as well as respiratory care.

Neuromuscular Disorders market report bar graph

What Is The Neuromuscular Disorders Market Size and Share 2026?

The neuromuscular disorders market size has grown strongly in recent years. It will grow from $8.31 billion in 2025 to $8.98 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing prevalence of genetic neuromuscular conditions, rising awareness about early diagnosis and treatment options, growing demand for effective therapies for rare disorders, increasing research initiatives in muscular dystrophy and ALS, and rising adoption of advanced diagnostic technologies.

What Is The Neuromuscular Disorders Market Growth Forecast?

The neuromuscular disorders market size is expected to see strong growth in the next few years. It will grow to $12.07 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rising patient advocacy and support group activities, growing demand for biologics and gene therapies, increasing recognition of neuromuscular disorders in pediatrics, rising government initiatives for rare disease management, and growing emphasis on home-based care and rehabilitation services. Major trends in the forecast period include advancement in gene-editing technologies for targeted therapies, innovation in RNA-based treatment platforms, integration of AI for faster neuromuscular diagnosis, advancement in stem-cell-based regenerative treatments, and innovation in wearable devices for continuous patient monitoring.

Book your 30 minutes free consultation with our research experts

Global Neuromuscular Disorders Market Segmentation

1) By Disease Type: Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS), Duchenne Muscular Dystrophy (DMD), Myasthenia Gravis, Other Muscular Dystrophies

2) By Product Type: Pharmaceuticals, Biologics, Diagnostic Tools, Assistive Devices

3) By Route of Administration: Oral, Injectable, Other Route of Administrations

4) By Treatment: Gene Therapy, Drug Therapy, RNA-Based Therapy, Enzyme Replacement Therapy, Physical Therapy And Rehabilitation, Respiratory Care

Subsegments:

1) By Spinal Muscular Atrophy: SMA Type 1, SMA Type 2, SMA Type 3, SMA Type 4, SMA with Respiratory Distress (SMARD)

2) By Amyotrophic Lateral Sclerosis: Sporadic ALS, Familial ALS, Limb-Onset ALS, Bulbar-Onset ALS, Respiratory-Onset ALS

3) By Duchenne Muscular Dystrophy: Early-Onset DMD, Late-Onset DMD, Exon Deletion Mutations, Exon Duplication Mutations, Point Mutations

4) By Myasthenia Gravis: Generalized Myasthenia Gravis, Ocular Myasthenia Gravis, Seropositive MG, MuSK-Positive MG, Seronegative MG

5) By Other Muscular Dystrophies: Becker Muscular Dystrophy (BMD), Limb-Girdle Muscular Dystrophy (LGMD), Facioscapulohumeral Muscular Dystrophy (FSHD), Congenital Muscular Dystrophies, Myotonic Dystrophy

What Is The Driver Of The Neuromuscular Disorders Market?

The rising demand for personalized medicine is expected to propel the growth of the neuromuscular disorders market going forward. Personalized medicine is a medical approach that involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and improve care. The demand for personalized medicine is increasing due to advancements in genomic technologies, which enable the precise identification of genetic variations and tailored treatments for individuals. Personalized medicine enhances neuromuscular disorder management by tailoring treatments based on individual genetic, molecular, and physiological profiles. It improves patient outcomes by enabling targeted therapies, optimizing efficacy, and minimizing adverse effects. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the neuromuscular disorders industry.

Key Players In The Global Neuromuscular Disorders Market

Major companies operating in the neuromuscular disorders market are AbbVie Inc., Novartis AG, Takeda Pharmaceutical Company Limited, The Trustees of the University of Pennsylvania, Biogen Inc., Sarepta Therapeutics Inc., argenx SE, PTC Therapeutics Inc., Catalyst Pharmaceuticals Inc., Mayo Clinic Laboratories, Fulgent Genetics Inc., Dyne Therapeutics Inc., The Regents of the University of California, GeneDx LLC, PepGen Inc., Centogene N.V., Scholar Rock Holding Corporation, Solid Biosciences Inc., Vita Therapeutics Inc., NMD Pharma A/S, Cytokinetics Incorporated, Sudo Biosciences Inc.

Global Neuromuscular Disorders Market Trends and Insights

Major companies operating in the neuromuscular disorders market are focusing on developing advanced treatments, such as gene replacement therapies, to address the underlying genetic causes of conditions such as Duchenne muscular dystrophy and spinal muscular atrophy. Gene replacement therapy refers to engineered biological products that deliver functional copies of defective genes to restore or improve muscle function in patients with inherited neuromuscular conditions, offering a potential one-time treatment that reduces the need for long-term chronic therapy. For instance, in November 2025, Novartis, a Switzerland-based pharmaceuticals company, received the US Food and Drug Administration (FDA) approval for Itvisma (onasemnogeneabeparvovec-brve), the first and only gene replacement therapy for the treatment of children two years of age and older, teens, and adults with spinal muscular atrophy (SMA) who have a confirmed mutation in the survival motor neurone 1 (SMN1) gene. It is specifically made to treat the genetic underlying cause of SMA with a single, fixed dosage that doesn't require body weight or age adjustments. Itvisma can enhance motor function by substituting the SMN1 gene, which may lessen the requirement for long-term medication used in conjunction with other current treatments for this population.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Neuromuscular Disorders Market?

In July 2023, Novartis AG, a Switzerland-based pharmaceutical company, acquired DTx Pharma Inc. for an undisclosed amount. Through this acquisition, Novartis enhanced its RNA-based therapeutic capabilities by adding DTx’s proprietary FALCON siRNA platform and advancing early-stage programs targeting neuromuscular disorders such as Charcot-Marie-Tooth disease type 1A. DTx Pharma Inc. is a US-based biotechnology company developing siRNA therapies for neurological and neuromuscular indications

Regional Insights

North America was the largest region in the neuromuscular disorders market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neuromuscular Disorders Market?

The neuromuscular disorders market consists of revenues earned by entities through diagnostic testing, therapeutic interventions, genetic counseling, rehabilitation therapy, and long-term patient management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neuromuscular Disorders Market Report 2026?

The neuromuscular disorders market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neuromuscular disorders industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Neuromuscular Disorders Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$8.98 billion
Revenue Forecast In 2035	$12.07 billion
Growth Rate	CAGR of 8.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Disease Type, Product Type, Route of Administration, Treatment
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	AbbVie Inc., Novartis AG, Takeda Pharmaceutical Company Limited, The Trustees of the University of Pennsylvania, Biogen Inc., Sarepta Therapeutics Inc., argenx SE, PTC Therapeutics Inc., Catalyst Pharmaceuticals Inc., Mayo Clinic Laboratories, Fulgent Genetics Inc., Dyne Therapeutics Inc., The Regents of the University of California, GeneDx LLC, PepGen Inc., Centogene N.V., Scholar Rock Holding Corporation, Solid Biosciences Inc., Vita Therapeutics Inc., NMD Pharma A/S, Cytokinetics Incorporated, Sudo Biosciences Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Neuromuscular Disorders Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Neuromuscular Disorders Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Neuromuscular Disorders Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Neuromuscular Disorders Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Gene-Based Therapies

4.2.2 Rising Use Of Advanced Diagnostic Tools

4.2.3 Growing Focus On Multidisciplinary Care Approaches

4.2.4 Expansion Of Supportive And Assistive Technologies

4.2.5 Enhanced Emphasis On Early Diagnosis

5. Neuromuscular Disorders Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Neurology Clinics

5.3 Rehabilitation Centers

5.4 Research Institutions

5.5 Home Healthcare Providers

6. Neuromuscular Disorders Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neuromuscular Disorders Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Neuromuscular Disorders PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Neuromuscular Disorders Market Size, Comparisons And Growth Rate Analysis

7.3. Global Neuromuscular Disorders Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Neuromuscular Disorders Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neuromuscular Disorders Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neuromuscular Disorders Market Segmentation

9.1. Global Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS), Duchenne Muscular Dystrophy (DMD), Myasthenia Gravis, Other Muscular Dystrophies

9.2. Global Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceuticals, Biologics, Diagnostic Tools, Assistive Devices

9.3. Global Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Injectable, Other Route of Administrations

9.4. Global Neuromuscular Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gene Therapy, Drug Therapy, RNA-Based Therapy, Enzyme Replacement Therapy, Physical Therapy And Rehabilitation, Respiratory Care

9.5. Global Neuromuscular Disorders Market, Sub-Segmentation Of Spinal Muscular Atrophy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

SMA Type 1, SMA Type 2, SMA Type 3, SMA Type 4, SMA with Respiratory Distress (SMARD)

9.6. Global Neuromuscular Disorders Market, Sub-Segmentation Of Amyotrophic Lateral Sclerosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sporadic ALS, Familial ALS, Limb-Onset ALS, Bulbar-Onset ALS, Respiratory-Onset ALS

9.7. Global Neuromuscular Disorders Market, Sub-Segmentation Of Duchenne Muscular Dystrophy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early-Onset DMD, Late-Onset DMD, Exon Deletion Mutations, Exon Duplication Mutations, Point Mutations

9.8. Global Neuromuscular Disorders Market, Sub-Segmentation Of Myasthenia Gravis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Generalized Myasthenia Gravis, Ocular Myasthenia Gravis, Seropositive MG, MuSK-Positive MG, Seronegative MG

9.9. Global Neuromuscular Disorders Market, Sub-Segmentation Of Other Muscular Dystrophies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Becker Muscular Dystrophy (BMD), Limb-Girdle Muscular Dystrophy (LGMD), Facioscapulohumeral Muscular Dystrophy (FSHD), Congenital Muscular Dystrophies, Myotonic Dystrophy

10. Neuromuscular Disorders Market Regional And Country Analysis

10.1. Global Neuromuscular Disorders Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Neuromuscular Disorders Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neuromuscular Disorders Market

11.1. Asia-Pacific Neuromuscular Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neuromuscular Disorders Market

12.1. China Neuromuscular Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neuromuscular Disorders Market

13.1. India Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neuromuscular Disorders Market

14.1. Japan Neuromuscular Disorders Market Overview

14.2. Japan Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neuromuscular Disorders Market

15.1. Australia Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neuromuscular Disorders Market

16.1. Indonesia Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neuromuscular Disorders Market

17.1. South Korea Neuromuscular Disorders Market Overview

17.2. South Korea Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neuromuscular Disorders Market

18.1. Taiwan Neuromuscular Disorders Market Overview

18.2. Taiwan Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neuromuscular Disorders Market

19.1. South East Asia Neuromuscular Disorders Market Overview

19.2. South East Asia Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neuromuscular Disorders Market

20.1. Western Europe Neuromuscular Disorders Market Overview

20.2. Western Europe Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neuromuscular Disorders Market

21.1. UK Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neuromuscular Disorders Market

22.1. Germany Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neuromuscular Disorders Market

23.1. France Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neuromuscular Disorders Market

24.1. Italy Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neuromuscular Disorders Market

25.1. Spain Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neuromuscular Disorders Market

26.1. Eastern Europe Neuromuscular Disorders Market Overview

26.2. Eastern Europe Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neuromuscular Disorders Market

27.1. Russia Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neuromuscular Disorders Market

28.1. North America Neuromuscular Disorders Market Overview

28.2. North America Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neuromuscular Disorders Market

29.1. USA Neuromuscular Disorders Market Overview

29.2. USA Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neuromuscular Disorders Market

30.1. Canada Neuromuscular Disorders Market Overview

30.2. Canada Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neuromuscular Disorders Market

31.1. South America Neuromuscular Disorders Market Overview

31.2. South America Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neuromuscular Disorders Market

32.1. Brazil Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neuromuscular Disorders Market

33.1. Middle East Neuromuscular Disorders Market Overview

33.2. Middle East Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neuromuscular Disorders Market

34.1. Africa Neuromuscular Disorders Market Overview

34.2. Africa Neuromuscular Disorders Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neuromuscular Disorders Market Regulatory and Investment Landscape

36. Neuromuscular Disorders Market Competitive Landscape And Company Profiles

36.1. Neuromuscular Disorders Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Neuromuscular Disorders Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Neuromuscular Disorders Market Company Profiles

36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.4. The Trustees of the University of Pennsylvania Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Neuromuscular Disorders Market Other Major And Innovative Companies

Sarepta Therapeutics Inc., argenx SE, PTC Therapeutics Inc., Catalyst Pharmaceuticals Inc., Mayo Clinic Laboratories, Fulgent Genetics Inc., Dyne Therapeutics Inc., The Regents of the University of California, GeneDx LLC, PepGen Inc., Centogene N.V., Scholar Rock Holding Corporation, Solid Biosciences Inc., Vita Therapeutics Inc., NMD Pharma A/S

38. Global Neuromuscular Disorders Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neuromuscular Disorders Market

40. Neuromuscular Disorders Market High Potential Countries, Segments and Strategies

40.1 Neuromuscular Disorders Market In 2030 - Countries Offering Most New Opportunities

40.2 Neuromuscular Disorders Market In 2030 - Segments Offering Most New Opportunities

40.3 Neuromuscular Disorders Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Neuromuscular Disorders Market, Overview Of Key Products - Product Examples

Table 2: Global Neuromuscular Disorders Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Neuromuscular Disorders Market, Supply Chain Analysis

Table 4: Global Neuromuscular Disorders Market, Major Raw Material Providers

Table 5: Global Neuromuscular Disorders Market, Major Resource Providers

Table 6: Global Neuromuscular Disorders Market, Major Manufacturers (Suppliers)

Table 7: Global Neuromuscular Disorders Market, Major Distributors And Channel Partners

Table 8: Global Neuromuscular Disorders Market, Key Technologies & Future Trends

Table 9: Global Neuromuscular Disorders Market, Major Trends

Table 10: Global Neuromuscular Disorders Market, Major End Users

Table 11: Global Neuromuscular Disorders Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Neuromuscular Disorders Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Neuromuscular Disorders Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Neuromuscular Disorders Market - TAM, US$ Billion, 2025

Table 15: Global Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Neuromuscular Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Neuromuscular Disorders Market, Sub-Segmentation Of Spinal Muscular Atrophy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Neuromuscular Disorders Market, Sub-Segmentation Of Amyotrophic Lateral Sclerosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Neuromuscular Disorders Market, Sub-Segmentation Of Duchenne Muscular Dystrophy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Neuromuscular Disorders Market, Sub-Segmentation Of Myasthenia Gravis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Neuromuscular Disorders Market, Sub-Segmentation Of Other Muscular Dystrophies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Neuromuscular Disorders Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Neuromuscular Disorders Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Neuromuscular Disorders Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Neuromuscular Disorders Market - Company Scoring Matrix

Table 100: AbbVie Inc. Financial Performance

Table 101: Novartis AG Financial Performance

Table 102: Takeda Pharmaceutical Company Limited Financial Performance

Table 103: The Trustees of the University of Pennsylvania Financial Performance

Table 104: Biogen Inc. Financial Performance

Table 105: Global Neuromuscular Disorders Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Neuromuscular Disorders Market, Competitive Dashboard

Table 107: Global Neuromuscular Disorders Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Neuromuscular Disorders Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030

Table 109: Global, Neuromuscular Disorders Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 110: Global, Neuromuscular Disorders Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Neuromuscular Disorders Market, Overview Of Key Products - Product Examples

Figure 2: Global Neuromuscular Disorders Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Neuromuscular Disorders Market, Supply Chain Analysis

Figure 4: Global Neuromuscular Disorders Market, Major Raw Material Providers

Figure 5: Global Neuromuscular Disorders Market, Major Resource Providers

Figure 6: Global Neuromuscular Disorders Market, Major Manufacturers (Suppliers)

Figure 7: Global Neuromuscular Disorders Market, Major Distributors And Channel Partners

Figure 8: Global Neuromuscular Disorders Market, Key Technologies & Future Trends

Figure 9: Global Neuromuscular Disorders Market, Major Trends

Figure 10: Global Neuromuscular Disorders Market, Major End Users

Figure 11: Global Neuromuscular Disorders Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Neuromuscular Disorders Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Neuromuscular Disorders Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Neuromuscular Disorders Market - TAM, US$ Billion, 2025

Figure 15: Global Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Neuromuscular Disorders Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Neuromuscular Disorders Market, Sub-Segmentation Of Spinal Muscular Atrophy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Neuromuscular Disorders Market, Sub-Segmentation Of Amyotrophic Lateral Sclerosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Neuromuscular Disorders Market, Sub-Segmentation Of Duchenne Muscular Dystrophy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Neuromuscular Disorders Market, Sub-Segmentation Of Myasthenia Gravis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Neuromuscular Disorders Market, Sub-Segmentation Of Other Muscular Dystrophies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Neuromuscular Disorders Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Neuromuscular Disorders Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Neuromuscular Disorders Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Neuromuscular Disorders Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Neuromuscular Disorders Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Neuromuscular Disorders Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Neuromuscular Disorders Market - Company Scoring Matrix

Figure 100: AbbVie Inc. Financial Performance

Figure 101: Novartis AG Financial Performance

Figure 102: Takeda Pharmaceutical Company Limited Financial Performance

Figure 103: The Trustees of the University of Pennsylvania Financial Performance

Figure 104: Biogen Inc. Financial Performance

Figure 105: Global Neuromuscular Disorders Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Neuromuscular Disorders Market, Competitive Dashboard

Figure 107: Global Neuromuscular Disorders Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Neuromuscular Disorders Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030

Figure 109: Global, Neuromuscular Disorders Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 110: Global, Neuromuscular Disorders Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Muscle Wasting Disorders Market Report 2026 - Global Outlook – By Treatment Type (Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types), By Disorder Type (Muscular Dystrophy, A...

Headache Disorders Market Report 2026 - Global Outlook – By Type (Migraine, Tension-Type Headache, Cluster Headache, Medication-Overuse Headache, Other Types), By Treatment (Medication, Heat Therapy, Diet Changes, Acupun...

Neurological Disorder Drugs Market Report 2026 - Global Outlook – By Drug Class (Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor Antagonists, Antiepileptic, Antipsychotic And Antidepressant, Other Drugs C...

Progressive Ataxia And Weakness Disorders Market Report 2026 - Global Outlook – By Type (Progressive Ataxia, Progressive Weakness Disorders), By Technology (Small Molecule, Monoclonal Antibody, Other Technology), By Dist...

Peripheral Neuropathy Market Report 2026 - Global Outlook – By Type (Chemotherapy-Induced, Diabetic, Human Immunodeficiency Virus (HIV) Or Acquired Immunodeficiency Syndrome (AIDS Associated), Idiopathic), By Diagnosis (...

Rare Neurological Disease Treatment Market Report 2026 - Global Outlook – By Drug Type (Biologics, Small Molecules), By Therapy (Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Disease-Modifying Neurological T...

Neuroendovascular Coil Market Report 2026 - Global Outlook – By Product Type (Guglielmi Detachable Coils (GDCs), Matrix Coils), By Indication (Ruptured Aneurysm, Unruptured Aneurysm), By Application (Medical Teaching, Ce...

Frequently Asked Questions

How big is the Neuromuscular Disorders Market?

The Neuromuscular Disorders market was valued at $8.31 billion in 2025, increased to $8.98 billion in 2026, and is projected to reach $12.07 billion by 2030.

What is the Neuromuscular Disorders market growth?

The global Neuromuscular Disorders market is expected to grow at a CAGR of 7.7% from 2026 to 2035 to reach $12.07 billion by 2035.

Who are the key players in Neuromuscular Disorders market?

Some Key Players in the Neuromuscular Disorders market Include, AbbVie Inc., Novartis AG, Takeda Pharmaceutical Company Limited, The Trustees of the University of Pennsylvania, Biogen Inc., Sarepta Therapeutics Inc., argenx SE, PTC Therapeutics Inc., Catalyst Pharmaceuticals Inc., Mayo Clinic Laboratories, Fulgent Genetics Inc., Dyne Therapeutics Inc., The Regents of the University of California, GeneDx LLC, PepGen Inc., Centogene N.V., Scholar Rock Holding Corporation, Solid Biosciences Inc., Vita Therapeutics Inc., NMD Pharma A/S, Cytokinetics Incorporated, Sudo Biosciences Inc. .

What is the anticipated growth trend for the Neuromuscular Disorders market?

Major trend in this market includes: Expansion Of Gene Therapy Options Improves Treatment Access Across Age Groups. For further insights on this market. request a sample here

Which region has the most growth potential in the Neuromuscular Disorders market?

North America was the largest region in the neuromuscular disorders market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuromuscular disorders market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.